Collin Hovinga

Dedicated professional in rare disease and pediatric drug development. Experience in medical strategy, clinical trials, regulatory affairs, novel trial designs, use of RWD and site and CRO management.

c-path.org

iactc.org

clevelandclinic.org

fda.gov

supportdellchildrens.org

uthsc.edu

Contact info

collin-hovinga

Experience

Vice President of Rare and Orphan Diseases

Critical Path Institute (C-Path)

• www.linkedin.com/company/c-path

Oct 2022 - Present

SGE Drug Safety and Risk Management Advisory (DSaRM) Committee

FDA

• www.linkedin.com/company/fda

Jun 2020 - Present

Silver Spring, Maryland, United States

Clinical Associate Professor

The University of Texas at Austin, College of Pharmacy

• www.linkedin.com/company/utexaspharmacy

Jan 2011 - Present

Austin, Texas Area

Senior Vice President of Clinical and Scientific Affairs

Institute for Advanced Clinical Trials for Children (I-ACT for Children)

• www.linkedin.com/company/institute-for-advanced-clinical-trials-for-children

Mar 2018 - Oct 2022

Rockville, MD

Director of Research Support Services

Ascension Texas (Seton Family Hospitals, Dell Children's Medical Center, Providence)

Nov 2015 - Mar 2018